Common and specific effects of TIE2 mutations causing venous malformations

Human Molecular Genetics

Volumn 24, Issue 22, 2015, Pages 6374-6389

  Nätynki, Marjut ^a   Kangas, Jaakko ^a   Miinalainen, Ilkka ^a   Sormunen, Raija ^a,b   Pietila Riikka ^a   Soblet, Julie ^c   Boon, Laurence M ^c,d   Vikkula, Miikka ^c   Limaye, Nisha ^c   Eklund, Lauri ^a  

^a UNIVERSITY OF OULU   (Finland)

^b OULU UNIVERSITY HOSPITAL   (Finland)

^c DE DUVE INSTITUTE   (Belgium)

^d CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN RECEPTOR; APROTININ; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PLASMIN; PLASMINOGEN; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE; FIBRIN DEGRADATION PRODUCT; FIBRIN FRAGMENT D; LIGAND;

AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INTERACTION; CELL JUNCTION; CELL LYSATE; CELL MEMBRANE; CELL MIGRATION; CELL STRUCTURE; CELL TRANSPLANTATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOSKELETON; ENDOPLASMIC RETICULUM; ENDOTHELIUM CELL; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; GENE MUTATION; GLYCOSYLATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DEPLETION; PROTEIN GLYCOSYLATION; PROTEIN METABOLISM; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; PROTEIN SYNTHESIS INHIBITION; RECEPTOR UPREGULATION; SCANNING ELECTRON MICROSCOPY; SIGNAL TRANSDUCTION; SOMATIC MUTATION; TRANSMISSION ELECTRON MICROSCOPY; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULARIZATION; VEIN MALFORMATION; ANIMAL; CELL MOTION; CONGENITAL BLOOD VESSEL MALFORMATION; ENZYMOLOGY; FEMALE; GENETICS; METABOLISM; MULTICELLULAR SPHEROID; MUTATION; PHOSPHORYLATION; SCID MOUSE;

AMINO ACID SUBSTITUTION; ANIMALS; CELL MOVEMENT; ENDOTHELIAL CELLS; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LIGANDS; MICE; MICE, SCID; MUTATION; PHOSPHORYLATION; RECEPTOR, TIE-2; SIGNAL TRANSDUCTION; SPHEROIDS, CELLULAR; VASCULAR MALFORMATIONS;

EID: 84949057867     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddv349     Document Type: Article

References (54)

1. Dompmartin, A., Vikkula, M. and Boon, L.M. (2010) Venous malformation: update on aetiopathogenesis, diagnosis and management. Phlebology, 25, 224-235.
2. Boon, L.M. and Vikkula, M. (2012) Vascular malformations. In Lowell, A., Goldsmith, S.I., Katz, B.A., Gilchrest, A. S., Paller, D.J. and Leffell, K.W.(eds), Fitzpatrick's Dermatology in General Medicine. Mcgraw-Hill Professional Publishing,New York, NY, USA.
3. Soblet, J., Limaye, N., Uebelhoer, M., Boon, L.M. and Vikkula, M. (2013) Variable somatic TIE2 mutations in half of sporadic venous malformations. Mol. Syndromol., 4, 179-183.
4. Limaye, N., Wouters, V., Uebelhoer, M., Tuominen, M., Wirkkala, R., Mulliken, J.B., Eklund, L., Boon, L.M. and Vikkula, M. (2009) Somatic mutations in angiopoietin receptor gene TEK cause solitary and multiple sporadic venous malformations. Nat. Genet., 41, 118-124.
5. Wouters, V., Limaye, N., Uebelhoer, M., Irrthum, A., Boon, L.M., Mulliken, J.B., Enjolras, O., Baselga, E., Berg, J., Dompmartin, A. et al. (2010) Hereditary cutaneomucosal venous malformations are caused by TIE2 mutations with widely variable hyper-phosphorylating effects. Eur. J. Hum. Genet., 18, 414-420.
6. Uebelhoer, M., Nätynki, M., Kangas, J., Mendola, A., Nguyen, H.L., Soblet, J., Godfraind, C., Boon, L.M., Eklund, L., Limaye, N. et al. (2013) Venous malformation-causative TIE2 mutations mediate an AKT-dependent decrease in PDGFB. Hum. Mol. Genet., 22, 3438-3448.
7. Vikkula, M., Boon, L.M., Carraway, K.L., Calvert, J.T., Diamonti, A.J., Goumnerov, B., Pasyk, K.A., Marchuk, D.A., Warman, M.L., Cantley, L.C. et al. (1996) Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. Cell, 87, 1181-1190.
8. Shewchuk, L.M., Hassell, A.M., Ellis, B., Holmes, W.D., Davis, R., Horne, E.L., Kadwell, S.H., Mckee, D.D. and Moore, J.T. (2000) Structure of the Tie2 RTK domain-self-inhibition by the nucleotide binding loop, activation loop, and C-terminal tail.Structure, 8, 1105-1113.
9. Dompmartin, A., Ballieux, F., Thibon, P., Lequerrec, A., Hermans, C., Clapuyt, P., Barrellier, M.T., Hammer, F., Labbé, D., Vikkula, M. et al. (2009) Elevated ?-dimer level in the differential diagnosis of venous malformations. Arch. Dermatol., 145, 1239-1244.
10. Dompmartin, A., Acher, A., Thibon, P., Tourbach, S., Hermans, C., Deneys, V., Pocock, B., Lequerrec, A., Labbé, D., Barrellier, M.T. et al. (2008) Association of localized intravascular coagulopathy with venous malformations. Arch. Dermatol., 144, 873-877.
11. Redondo, P., Aguado, L., Marquina, M., Paramo, J., Sierra, A.,Sánchez-Ibarrola, A., Martínez-Cuesta, A. and Cabrera,J.(2010) Angiogenic and prothrombotic markers in extensive 4slow-flow vascular malformations: implications for antiangiogenic/antithrombotic strategies. Br. J. Dermatol.,162, 350-356.
12. Mazoyer, E., Enjolras, O., Bisdorff, A., Perdu, J.,Wassef, M. and Drouet, L. (2008) Coagulation disorders in patients with venous malformation of the limbs and trunk: a case series of 118 patients. Arch. Dermatol., 144, 861-867.
13. Fukuhara, S., Sako, K., Minami, T., Noda, K., Kim, H.Z., Kodama, T., Shibuya, M., Takakura, N., Koh, G.Y. and Mochizuki, N. (2008) Differential function of Tie2 at cell-cell contacts and cell-substratum contacts regulated by angiopoietin-1. Nat. Cell. Biol., 10, 513-526.
14. Saharinen, P., Eklund, L., Miettinen, J.,Wirkkala, R., Anisimov, A.,Winderlich, M., Nottebaum, A., Vestweber, D., Deutsch, U., Koh, G.Y. et al. (2008) Angiopoietins assemble distinct Tie2 signalling complexes in endothelial cell-cell and cell-matrix contacts. Nat. Cell. Biol., 10, 527-537.
15. Pietilä, R., Nätynki, M., Tammela, T., Kangas, J., Pulkki, K.H., Limaye, N., Vikkula, M., Koh, G.Y., Saharinen, P., Alitalo, K. et al. (2012) Ligand oligomerization state controls Tie2 receptor trafficking and angiopoietin-2-specific responses. J. Cell. Sci., 125, 2212-2223.
16. Kim, I., Kim, H.G., So, J.N., Kim, J.H., Kwak, H.J. and Koh, G.Y. (2000) Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Circ. Res., 86, 24-29.
17. Yoon, M.J., Cho, C.H., Lee, C.S., Jang, I.H., Ryu, S.H. and Koh, G.Y. (2003) Localization of Tie2 and phospholipase D in endothelial caveolae is involved in angiopoietin-1-induced MEK/ ERK phosphorylation and migration in endothelial cells. Biochem. Biophys. Res. Commun., 308, 101-105.
18. Kontos, C.D., Stauffer, T.P., Yang, W.P., York, J.D., Huang, Li., Blanar, M.A., Meyer, T. and Peters, K.G. (1998) Tyrosine 1101 of Tie2 is the major site of association of p85 and is required for activation of phosphatidylinositol 3-kinase and Akt. Mol. Cell. Biol., 18, 4131-4140.
19. Jones, N., Master, Z., Jones, J., Bouchard, D., Gunji, Y., Sasaki, H., Daly, R., Alitalo, K. and Dumont, D.J. (1999) Identification of Tek/Tie2 binding partners: binding to a multifunctional docking site mediates cell survival and migration. J. Biol. Chem., 274, 30896-30905.
20. Lievens, P.M.J., Mutinelli, C., Baynes, D. and Liboi, E. (2004) The kinase activity of fibroblast growth factor receptor 3 with activation loop mutations affects receptor trafficking and signaling. J. Biol. Chem., 279, 43254-43260.
21. Tabone-Eglinger, S., Subra, F., El Sayadi, H., Alberti, L., Tabone, E., Michot, J.P., Théou-Anton, N., Lemoine, A., Blay, J.Y. and Emile, J.F. (2008) KIT mutations induce intracellular retention and activation of an immature form of the KIT protein in gastrointestinal stromal tumors. Clin. Cancer Res., 14, 2285-2294.
22. Hatch, N.E., Hudson, M., Seto, M.L., Cunningham, M.L. and Bothwell, M. (2006) Intracellular retention, degradation, and signaling of glycosylation-deficient FGFR2 and craniosynostosis syndrome-associated FGFR2C278F. J. Biol. Chem., 281, 27292-27305.
23. Contessa, J.N., Bhojani, M.S., Freeze, H.H., Rehemtulla, A. and Lawrence, T.S. (2008) Inhibition of N-linked glycosylation disrupts receptor tyrosine kinase signaling in tumor cells. Cancer. Res., 68, 3803-3809.
24. Bass, J., Chiu, G., Argon, Y. and Steiner, D.F. (1998) Folding of insulin receptor monomers is facilitated by the molecular chaperones calnexin and calreticulin and impaired by rapid dimerization. J. Cell. Biol., 141, 637-646.
25. Schmidt-Arras, D.E., Böhmer, A., Markova, B., Choudhary, C., Serve, H. and Böhmer, F.D. (2005) Tyrosine phosphorylation regulates maturation of receptor tyrosine kinases. Mol. Cell Biol., 25, 3690-3703.
26. Huang, L., Turck, C.W., Rao, P. and Peters, K.G. (1995) GRB2 and SH-PTP2: potentially important endothelial signaling molecules downstream of the TEK/TIE2 receptor tyrosine kinase. Oncogene., 11, 2097-2103.
27. Hurt, C.M., Ho, V.K. and Angelotti, T. (2013) Systematic and quantitative analysis of G protein-coupled receptor trafficking motifs. Methods Enzymol., 521, 171-187.
28. Yamakawa, D., Kidoya, H., Sakimoto, S., Jia,W., Naito, H. and Takakura, N. (2013) Ligand-independent Tie2 dimers mediate kinase activity stimulated by high dose angiopoietin-1. J. Biol. Chem., 288, 12469-12477.
29. Bogdanovic, E., Nguyen, V.P.K.H. and Dumont, D.J. (2006) Activation of Tie2 by angiopoietin-1 and angiopoietin-2 results in their release and receptor internalization. J. Cell. Sci., 119, 3551-3560.
30. Reusch, P., Barleon, B.,Weindel, K., Martiny-Baron, G., Gödde, A., Siemeister, G. and Marmé, D. (2001) Identification of a soluble form of the angiopoietin receptor TIE-2 released from endothelial cells and present in human blood. Angiogenesis, 4, 123-131.
31. Findley, C.M., Cudmore, M.J., Ahmed, A. and Kontos, C.D. (2007) VEGF induces Tie2 shedding via a phosphoinositide 3-kinase/Akt dependent pathway to modulate Tie2 signaling. Arterioscler. Thromb. Vasc. Biol., 27, 2619-2626.
32. Suri, C., Jones, P.F., Patan, S., Bartunkova, S., Maisonpierre, P.C., Davis, S., Sato, T.N. and Yancopoulos, G.D. (1996) Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell, 87, 1171-1180.
33. Jeansson, M., Gawlik, A., Anderson, G., Li, C., Kerjaschki, D., Henkelman, M. and Quaggin, S.E. (2011) Angiopoietin-1 is essential in mouse vasculature during development and in response to injury. J. Clin. Invest., 121, 2278-2289.
34. Cseh, B., Fernandez-Sauze, S., Grall, D., Schaub, S., Doma, E. and Van Obberghen-Schilling, E. (2010) Autocrine fibronectin directs matrix assembly and crosstalk between cell-matrix and cell-cell adhesion in vascular endothelial cells. J. Cell Sci., 123, 3989-3999.
35. Birdwell, C.R., Gospodarowicz, D. and Nicolson, G.L. (1978) Identification, localization, and role of fibronectin in cultured bovine endothelial cells. Proc. Natl. Acad. Sci. USA, 75, 3273-3277.
36. Chen, L.B., Gallimore, P.H. and Mcdougall, J.K. (1976) Correlation between tumor induction and the large external transformation sensitive protein on the cell surface. Proc. Natl. Acad. Sci. USA, 73, 3570-3574.
37. Korff, T. and Augustin, H.G. (1999) Tensional forces in fibrillar extracellular matrices control directional capillary sprouting. J. Cell. Sci., 112, 3249-3258.
38. Morris, P.N., Dunmore, B.J., Tadros, A., Marchuk, D.A., Darland, D.C., D'Amore, P.A. and Brindle, N.P.J. (2005) Functional analysis of a mutant form of the receptor tyrosine kinase Tie2 causing venous malformations. J. Mol. Med., 83, 58-63.
39. Murphy, P.A., Kim, T.N., Huang, L., Nielsen, C.M., Lawton, M.T., Adams, R.H., Schaffer, C.B. and Wang, R.A. (2014) Constitutively active Notch4 receptor elicits brain arteriovenous malformations through enlargement of capillary-like vessels. Proc. Natl. Acad. Sci. USA, 111, 1-6.
40. Kostourou, V. and Papalazarou, V. (2014) Non-collagenous ECM proteins in blood vessel morphogenesis and cancer. Biochim. Biophys. Acta Gen. Subj., 1840, 2403-2413.
41. Cascone, I., Napione, L., Maniero, F., Serini, G. and Bussolino, F. (2005) Stable interaction between alpha5beta1 integrin and Tie2 tyrosine kinase receptor regulates endothelial cell response to Ang-1. J. Cell Biol., 170, 993-1004.
42. George, B.E.L., Baldwin, H.S., Hynes, R.O. and George, E.L. (1997) Fibronectins are essential for heart and blood vessel morphogenesis but are dispensable for initial specification of precursor cells. Blood, 90, 3073-3081.
43. Liotta, L.A.,Goldfarb, R.H., Brundage, R., Siegal,G.P., Terranova,V. andGarbisa, S. (1981) Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane. Cancer Res., 41,4629-4636.
44. Baramova, E.N., Bajou, K., Remacle, A., L'Hoir, C., Krell, H.W., Weidle, U.K., Noel, A. and Foidart, J.M. (1997) Involvement of PA/plasmin system in the processing of pro-MMP-9 and in the second step of pro-MMP-2 activation. FEBS Lett., 405, 157-162.
45. Horowitz, J.C., Rogers, D.S., Simon, R.H., Sisson, T.H. and Thannickal, V.J. (2008) Plasminogen activation-induced pericellular fibronectin proteolysis promotes fibroblast apoptosis. Am. J. Respir. Cell Mol. Biol., 38, 78-87.
46. Houard, X., Monnot, C., Dive, V., Corvol, P. and Pagano, M. (2003) Vascular smooth muscle cells efficiently activate a newproteinase cascade involving plasminogen and fibronectin. J. Cell Biochem., 88, 1188-1201.
47. Bonnefoy, A. and Legrand, C. (2000) Proteolysis of subendothelial adhesive glycoproteins (fibronectin, thrombospondin, and von Willebrand factor) by plasmin, leukocyte cathepsin G, and elastase. Thromb. Res., 98, 323-332.
48. Montesano, R., Pepper, M.S., Möhle-Steinlein, U., Risau, W., Wagner, E.F. and Orci, L. (1990) Increased proteolytic activity is responsible for the aberrant morphogenetic behavior of endothelial cells expressing the middle Toncogene. Cell, 62, 435-445.
49. Sabapathy, K.T., Pepper, M.S., Kiefer, F., Möhle-steinlein, U., Tacchini-cottier, F., Fetka, I., Breier, G., Risau, W., Carmeliet, P., Montesano, R. et al. (1997) Polyoma middle T-induced vascular tumor formation: the role of the plasminogen activator/plasmin system. J. Cell. Biol., 137, 953-963.
50. Boscolo, E., Limaye, N., Huang, L., Kang, K.T., Soblet, J., Uebelhoer, M., Mendola, A., Natynki, M., Seront, E., Dupont, S. et al. (2015) Rapamycin improves TIE2-mutated venous malformation in murine model and human subjects. J. Clin. Invest., 125, 3491-3504.
51. Muldowney, J.A.S., Stringham, J.R., Levy, S.E., Gleaves, L.A., Eren, M., Piana, R.N. and Vaughan, D.E. (2007) Antiproliferative agents alter vascular plasminogen activator inhibitor-1 expression: a potential prothrombotic mechanism of drugeluting stents. Arterioscler. Thromb. Vasc. Biol., 27, 400-406.
52. Ory, D.S., Neugeboren, B.A. and Mulligan, R.C. (1996) A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes. Proc. Natl. Acad. Sci. USA, 93, 11400-11406.
53. Kitamura, T., Koshino, Y., Shibata, F., Oki, T., Nakajima, H., Nosaka, T. and Kumagai, H. (2003) Retrovirus-mediated gene transfer and expression cloning: powerful tools in functional genomics. Exp. Hematol., 31, 1007-1014.
54. Laib, A.M., Bartol, A., Alajati, A., Korff, T., Weber, H. and Augustin, H.G. (2009) Spheroid-based human endothelial cell microvessel formation in vivo. Nat. Protoc., 4, 1202-1215.